Biohaven (BHVN) Other Working Capital Changes (2021 - 2026)
Biohaven (BHVN) reported Other Working Capital Changes of -$1.6 million for Q4 2022, down 769.96% on a YoY basis from $233000.0 in Q4 2021, and down 769.96% sequentially from $233000.0 in Q4 2021.
Biohaven (BHVN) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Other Working Capital Changes data on file, last reported at -$12.6 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 273.58% year-over-year to -$12.6 million; the trailing twelve-month figure through Mar 2026 stood at -$23.3 million (down 580.86% YoY), and the FY2025 full-year result was -$3.5 million, up 56.1% from the prior year.
- Other Working Capital Changes declined to -$1.6 million in Q4 2022, from $233000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $233000.0 in Q4 2021 to a low of -$1.6 million in Q4 2022.
- A 5-year average of -$586941.2 and a median of $1.3 million in 2023 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes surged 1604.69% in 2022 and tumbled 765.58% in 2024, its largest moves.
- Tracing BHVN's Other Working Capital Changes over 5 years: stood at $25.7 million in 2022, then slumped by 95.12% to $1.3 million in 2023, then plunged by 765.58% to -$8.3 million in 2024, then fell by 5.78% to -$8.8 million in 2025, then tumbled by 42.53% to -$12.6 million in 2026.
- Business Quant data shows BHVN's Other Working Capital Changes at -$12.6 million in Q1 2026, -$8.8 million in Q4 2025, and -$6.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Biohaven | 2.13 Bn | 1.78 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.56 Mn |
| Mar 31, 2026 | -12.56 Mn |
| Mar 31, 2026 | -12.56 Mn |
| Dec 31, 2025 | -8.82 Mn |
| Dec 31, 2025 | -8.82 Mn |
| Dec 31, 2025 | -8.82 Mn |
| Sep 30, 2025 | -6.50 Mn |
| Sep 30, 2025 | -6.50 Mn |
| Sep 30, 2025 | -6.50 Mn |
| Jun 30, 2025 | 4.54 Mn |
| Jun 30, 2025 | 4.54 Mn |
| Jun 30, 2025 | 4.54 Mn |
| Mar 31, 2025 | 7.24 Mn |
| Mar 31, 2025 | 7.24 Mn |
| Mar 31, 2025 | 7.24 Mn |
| Dec 31, 2024 | -8.33 Mn |
| Dec 31, 2024 | -8.33 Mn |
| Dec 31, 2024 | -8.33 Mn |
| Sep 30, 2024 | -13.20 Mn |
| Sep 30, 2024 | -13.20 Mn |